Jamie Dimon's JPMorgan Posted a Record $21.2 Billion Quarterly Profit, Up 41%
Yahoo Finance ·
JPMorgan Chase ( JPM +0.92% ) just did something no U.S. bank has ever done. It earned $21.2 billion in a single quarter, up 41% from a year earlier, the largest quarterly profit in the history of American banking. Earnings per share jumped 47%, and every one of the bank's business lines set a record. Yet JPMorgan Chase CEO Jamie Dimon's reaction was telling. He called the environment "close to as good as it gets," then added, "We just don't know how long it's going to last." This was a quarter supercharged by Wall Street activity. Equity trading revenue surged 86% to $6 billion, and a big reason was the record-shattering initial public offering of Space Exploration Technologies , the largest IPO ever, which sent a wave of fees to the banks that ran it. Investment banking fees climbed 30% to $3.3 billion, their highest level since 2021, led by strength in equity underwriting. Total revenue rose 27% to $58 billion. A one-time gain tied to the bank's stake in Visa also padded the bottom line. JPMorgan Chase CEO Jamie Dimon. Image source: JPMorgan Chase & Co. Here is why I would not simply extrapolate this quarter, and I wouldn't expect continued optimism. Dimon's caveat, which he said during the earnings call, is the whole story. Trading booms and blockbuster IPOs are lumpy and unpredictable, and a deal like SpaceX's does not come along often. One-time gains, by definition, do not repeat.
AI 시장 분석
JPMorgan Chase reported a record quarterly profit of $21.2 billion, up 41% as Wall Street activities significantly increased the profit.
상승 영향
- Finance — JPMorgan Chase's record quarterly profit and the increase of Wall Street activities positively impacted the financial sector.
하락 영향
- Finance — Following Jamie Dimon's warning, the environment may fluctuate and quarterly profit may decrease.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 49% · Bearish (Short) 51%
439 participants
Related News
- Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
- Vale shareholders elect Oliveira chairman; Q2 iron ore output best since 2018
- Raymond James Financial Non-GAAP EPS of $3.14 beats by $0.23, revenue of $3.93B beats by $20M
- Toro Company names next CEO
- Wyndham Hotels & Resorts Non-GAAP EPS of $1.48 beats by $0.07, revenue of $375M misses by $25.8M
- American Healthcare REIT names new CEO
